New molecular scientific studies have offered several insights to the processes that govern the event and progression of CLL, including many novel mutated genes clustered in various purposeful pathways. The CLL epigenome is reprogrammed with the modulation of regulatory locations that show up de novo within the disorder, While other regions preserv